Latest Share Chat

REMOVE ADS

Hutchmed Share News (HCM)

Hutchmed Information

Share Price Information for Hutchmed (HCM)

Share Price is delayed by 15 minutes

Get Live Data

168.00 3.25 (1.97%)

Bid:

158.00

Ask:

162.00

Spread: 4.00 (2.532%)

Market Cap: £1.44b

Last checked at -

Intraday Hutchmed Share Chart

REMOVE ADS

Hutchmed News

UK earnings, trading statements calendar - next 7 days

Corporate News

Hutchmed China hails lung cancer trial results published in Lancet

(Alliance News) - Hutchmed China Ltd on Wednesday said the results from its SACHI phase-three lung cancer trial have been published in medical journal...

Hutchmed China hails sovleplenib results for form of anaemia in China

(Alliance News) - Hutchmed China Ltd on Wednesday announced topline results of a phase 3 trial of its selective small molecule inhibitor sovleplenib, ...

Hutchmed China kicks off phase three stage of pancreatic cancer trial

(Alliance News) - Hutchmed China Ltd on Monday said it has started the phase three part of a trial evaluating surufatinib and camrelizumab for the tre...

Hutchmed savolitinib NDA for gastric cancer accepted in China

(Alliance News) - Hutchmed China Ltd on Tuesday said Chinese regulators have accepted and granted priority review to its new drug application for savo...

Hutchmed drug gains China priority review for bile duct cancer

(Alliance News) - Hutchmed China Ltd on Monday said Chinese regulators have accepted a new drug application for its cancer treatment fanregratinib and...

Hutchmed launches development programme for next-gen therapy platform

(Sharecast News) - Hutchmed said on Wednesday that it has initiated a global phase one clinical development programme for HMPL-A251, marking the first...

Hutchmed China kicks off clinical development of ATTC candidate

(Alliance News) - Hutchmed China Ltd on Wednesday said it has begun the global phase one clinical development programme for its targeted cancer therap...